Parkinson Hastalığı Tedavisinde Manyetik Rezonans-Guided Odaklı Ultrason için Hedef Seçimi.
Target Selection for Magnetic Resonance-Guided Focused Ultrasound in the Treatment of Parkinson's Disease.
DOI: 10.1002/jmri.28080PMID: 35081263
Target Selection for Magnetic Resonance-Guided Focused Ultrasound in the Treatment of Parkinson's Disease.
DOI: 10.1002/jmri.28080PMID: 35081263
Uncoupling proteins as a therapeutic target for the development of new era drugs against neurodegenerative disorder.
DOI: 10.1016/j.biopha.2022.112656PMID: 35091238
Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis.
DOI: 10.1007/s10072-021-05829-4PMID: 35079903
Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson's disease: study protocol of a pilot add-on, randomised, controlled, pragmatic clinical trial.
DOI: 10.1186/s13020-022-00572-0PMID: 35073963
Indirect comparison of apomorphine sublingual film and levodopa inhalation powder for Parkinson's disease 'OFF' episodes.
DOI: 10.2217/cer-2021-0178PMID: 35068168
Management of Psychotic Symptoms in a Patient With Parkinson's Disease Maintained on Levodopa-Carbidopa Intestinal Gel by Paliperidone Long-Acting Injection: A Case Report.
DOI: 10.7759/cureus.21491PMID: 35223269
MicroRNAs Play a Role in Parkinson's Disease by Regulating Microglia Function: From Pathogenetic Involvement to Therapeutic Potential.
DOI: 10.3389/fnmol.2021.744942PMID: 35126050
A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases.
DOI: 10.3389/fncel.2021.787258PMID: 35126058
Technical Comparison of Treatment Efficiency of Magnetic Resonance-Guided Focused Ultrasound Thalamotomy and Pallidotomy in Skull Density Ratio-Matched Patient Cohorts.
DOI: 10.3389/fneur.2021.808810PMID: 35126300
Istradefylline: A novel agent in the treatment of "off" episodes associated with levodopa/carbidopa use in Parkinson disease.
DOI: 10.9740/mhc.2022.01.032PMID: 35116210
Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders.
DOI: 10.3390/ijms23031184PMID: 35163103
Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics.
DOI: 10.3390/jpm12020144PMID: 35207632
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.